ストックスクリーナーアプリを入手
16.22
4.14%
-0.70
アフターアワーズ：
16.21
-0.010
-0.06%
Generate Biomedicines Inc (GENB) 最新ニュース
Cathie Wood Likes That New Stock Smell: 3 IPO Stocks She Bought on Monday - The Motley Fool
If You Invested $1,000 in Generate Biomedicines (GENB) - Stock Titan
EBITDA of Generate Biomedicines, Inc. – BX:GENB - TradingView
Top Generate Biomedicines (GENB) Competitors 2026 - MarketBeat
GENBGenerate Biomedicines Inc Dividends - Finviz
Generate Biomedicines Inc. (GENB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Price to book forward of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Price to book forward of Generate Biomedicines, Inc. – BX:GENB - TradingView
Q&A: Generate Biomedicines CTO talks AI advancements - TechTarget
Generate Biomedicines, Inc.(NasdaqGS: GENB) added to Russell 2000 Index - marketscreener.com
Generate Biomedicines, Inc.(NasdaqGS: GENB) added to Russell 2000 Value Benchmark - marketscreener.com
Generate Biomedicines, Inc.(NasdaqGS: GENB) added to Russell 2000 Growth Benchmark - marketscreener.com
Generate Biomedicines, Inc.(NasdaqGS: GENB) added to Russell 3000E Growth Benchmark - marketscreener.com
Generate Biomedicines, Inc.(NasdaqGS: GENB) added to Russell 3000 Index - marketscreener.com
Generate Biomedicines, Inc.(NasdaqGS:GENB) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Generate Biomedicines stock ends week back above IPO price as volume jumps - TechStock²
Transcript : Generate Biomedicines, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 03 - marketscreener.com
Enterprise value to EBITDA forward of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Enterprise value to EBIT forward of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Enterprise value to EBIT forward of Generate Biomedicines, Inc. – BOATS:GENB - TradingView
Generate Biomedicines, Inc. Actuals & Estimates (NASDAQ:GENB) - TradingView
Generate Biomedicines, Inc. Actuals & Estimates (BOATS:GENB) - TradingView
Price to sales forward of Generate Biomedicines, Inc. – BOATS:GENB - TradingView
Price to earnings forward of Generate Biomedicines, Inc. – BOATS:GENB - TradingView
GENB Forecast — Price Target — Prediction for 2027 - TradingView
Guggenheim Maintains Generate Biomedicines(GENB.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Morgan Stanley Maintains an Overweight Rating on Generate Biomedicines, Inc. (GENB) - Yahoo Finance
AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts - Sahm
AdvanCell takes all of IQHQ’s 128,000-sq-ft Andover site - Stock Titan
Generate Biomedicines, Inc.(NasdaqGS: GENB) added to S&P TMI Index - marketscreener.com
Generate Biomedicines, Inc. (GENB) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Generate Biomedicines (GENB) Q1 2026 earnings summary - Quartr
IPO Tracker 2026: Cardio biotech Kardigan binds off $400M upsized IPO - BioSpace
Generate Biomedicines (GENB) News Flow - Moomoo
Generate Biomedicines Surges 9.69%: Breaking Resistance Levels in Biotech RallyIntraday Trade Ideas - newsline.com
Generate Biomedicines (GENB) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Generate Biomedicines, Inc. (GENB) Market Cap - Zacks Investment Research
Generate Biomedicines (GENB) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
GENB Price Today: Generate Biomedicines, Inc. Stock Price, Quote & Chart | MEXC - MEXC
Why Is Generate Biomedicines, Inc. (GENB) Stock Down Today? - Meyka
Generate Biomedicines (GENB) Tumbles 7% as Selling Pressure Mounts – Key Support Levels in FocusSentiment Shift - newsline.com
Why Is Generate Biomedicines, Inc. (GENB) Stock Up Today? - Meyka
A Look At Generate Biomedicines (GENB) Valuation As Shares Soften After Recent Gains - Yahoo Finance
Assessing Generate Biomedicines (GENB) Valuation As Losses Mount And Price To Book Sits At 3.3x - simplywall.st
A New $21 Million Position Signals Confidence in This Post-IPO Drug Developer - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Generate Biomedicines Inc. (GENB) Q1 2026 Earnings: Wider-than-Expected Loss Underscores Pre-Revenue Development StageEarnings Analysis - newsline.com
1.17%
2.48%
大文字化:
|
ボリューム (24 時間):